MEDICAL TECHNOLOGY START UP INTRODUCES NEW SOLUTION TO BLOOD SAMPLE ANALYSIS

https://d1qb2nb5cznatu.cloudfront.net/startups/i/5618288-67b8ea11c7369662b59f80980efcef23-medium_jpg.jpg?buster=1524052620

May 11, 2018 – A blood test is a laboratory analysis performed on a blood sample that is usually extracted from a vein in the arm using a hypodermic needle, or via finger prick. This laboratory method is often used in healthcare to determine physiological and biochemical states, such as disease, mineral content, pharmaceutical drug effectiveness, and organ function, and more recently, cancer, susceptibility to allergies and drug abuse levels. In some of the locales, a blood test is required before marriage.

Actress and philanthropist, Angelina Jolie, a breast cancer survivor, during an interview, emphasized on blood tests as a way to help women detect cancer before it becomes problematic. Her statement reads thus: “I hope that other women can benefit from my experience. Cancer is still a word that strikes fear into people’s hearts, producing a deep sense of powerlessness. But today it is possible to find out through a blood test whether you are highly susceptible to breast and ovarian cancer, and then take action. It is my hope that they, too, will be able to get gene tested, and that if they have a high risk they, too, will know that they have strong options.”

The inclusion of technology and its adaptation by the world of medicine has led to many breakthroughs in health science and helped achieved things that were next to impossible. But LAB.ME ANALYTICS has taken it a step further by introducing a new solution that allows blood work become less tedious. Now, with one simple photo of your blood work, you instantly know what needs attention. No more waiting, no more uncertainty. Lab.me uses machine intelligence to predict problems before they are apparent to the human eye.

Founders Anthony Close, serial Med-tech entrepreneur and CEO of LAB.ME and Gregg Lewis, serial entrepreneur and co-founder of LAB.ME have sold their innovative idea to the extent of getting $150,000 for the official launch of this life-changing medical technology, valued at a $2,500,000 valuation. The launch of the product took place on March 1st, 2018 but is still short of funds from properly taking flight into the medical world.

This is thereby targeted at Investors, Doctors, Nurses, and Patients who are willing to further advance the cause of efficiency in laboratory blood work.

Video Link: http://www.youtube.com/embed/suX3dhS7KnE

For more information on this, contact Jasmine Tumbelaka by visiting the website https://angel.co/lab-me-analytics

To sign up to be a premier user when the product takes flight, visit https://labme.simvoly.com/

Media Contact
Company Name: Lab Me Analytics
Contact Person: Jasmine Tumbelaka
Email: Send Email
Country: United States
Website: https://angel.co/lab-me-analytics